Robert Lanza Discusses Stem Cell Research Advances: “Berlin Patient” Said to be Cured of HIV

From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology

Robert Lanza has been in the forefront of stem cell research, with a breakthrough in deriving a “universal” blood supply from stem cells. In the current field of stem cell research, the blood research branch of stem cell research seems to have taken another great leap as, for the first time, a man has been reported as having been cured of HIV through stem cell therapy.

The struggle against AIDS has been considerable and has been an ongoing battle for many years, especially as the number of those infected continues to increase all over the world. That stem cells have now been conclusively proven (through extensive testing on the patient after the treatment) to have cured HIV marks a great advancement against the disease.

From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology

Robert Lanza’s universal blood research is but one part of blood-related stem cell research. The Berlin Patient, as he was dubbed, had undergone stem cell transplants, with stem cells coming from an individual with a unique genetic profile: a mutation that created CD4 cells that did not have CCR5 receptors. This type of homozygosity is present in less than 1% of Caucasians, and greatly reduces HIV risks in an individual.

Through these transplanted stem cells, the original HIV-host CD4 cells started to become overrun and consequently eclipsed by the new CD4 cells, eliminating the infection. The Berlin Patient’s success has been spreading like wildfire through the medical world and is lauded as a great achievement not only in the field, but in history, as well.

Robert Lanza’s own stem cell research advances can be found at www.robertlanza.com.

From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology